Engineer
Nanotechnology Engineer specializing in advanced materials, semiconductor physics, and bionanotechnology. I deliver engineering and R&D solutions spanning smart drug delivery systems, wearable biosensors, and nanomaterial fabrication to biotech firms, semiconductor companies, and research institutions looking to translate cutting-edge nanoscale innovation into scalable technologies.
Nanotechnology Engineer with a solid foundation in semiconductor physics, advanced materials, and biosensing technologies. Proven hands-on experience in laboratory research, micro- and nanoscale characterization, and complex engineering problem-solving. Passionate about translating nanoscience concepts into innovative applications across semiconductor and biotechnology sectors, with a continuous drive to bridge advanced scientific engineering with modern technological solutions.
Worked as a laboratory technician in the cell culture laboratory, performing cell culture techniques and supporting experimental procedures in a biomedical research environment.
Synthesized carbon nanotubes using Chemical Vapor Deposition (CVD), gaining hands-on experience in nanomaterial fabrication and laboratory-scale processes.
Focused on Nanomaterial-Mediated Drug Delivery in Cancer Therapy
Nanocarrier Systems Evaluation: Analyzed the physicochemical properties and surface dynamics of diverse nanocarriers (liposomes, polymeric nanoparticles, silica, and gold nanoparticles) to optimize circulation half-life and cellular uptake. Targeting Mechanisms & Biological Barriers: Investigated passive accumulation via the enhanced permeability and retention (EPR) effect alongside active targeting strategies utilizing surface-conjugated ligands to bypass systemic bio-barriers. Clinical & Regulatory Benchmarking: Evaluated FDA-approved nanomedicines (e.g., Doxil, Abraxane), comparing their pharmacokinetic profiles, biodistribution, and therapeutic indices against conventional chemotherapy protocols. Biocompatibility & Toxicity Assessment: Examined in vitro cytotoxicity pathways, immunological interactions, and accumulation risks, identifying surface modification techniques (e.g., PEGylation) to mitigate systemic toxicity. Computational & Emerging Frontiers: Explored future nanomedicine advancements, highlighting the integration of machine learning and computational modeling for predictive nanoparticle design and release optimization.
View project ↗